Bryant Jamie, Roberts-Barker Kayden, Mills Zabowie, Booth Kade, Foster Joley, Mersha Amanual Getnet, Maddox Raglan, Chamberlain Catherine, Bonevski Billie, Segan Cathy, Taylor Nathan, Kennedy Michelle
The University of Newcastle College of Health Medicine and Wellbeing, Callaghan, New South Wales, Australia
Equity in Health and Wellbeing Research Program, The University of Newcastle Hunter Medical Research Institute, New Lambton, New South Wales, Australia.
BMJ Open. 2024 Dec 20;14(12):e088501. doi: 10.1136/bmjopen-2024-088501.
Smoking is the leading preventable cause of death and the single most significant risk behaviour contributing to adverse health conditions among Aboriginal and Torres Strait Islander people. There is an urgent need for innovative approaches to support reductions in smoking prevalence. This study will assess the implementation and effectiveness of a mailed smoking cessation support programme that includes nicotine replacement therapy (NRT) () for Aboriginal and Torres Strait Islander people.
A hybrid type 1 effectiveness-implementation trial will be conducted in Australia from 2023 to 2025. A sample of 500 Aboriginal and Torres Strait Islander people aged over 16 who smoke will be recruited using social media. All participants will: (a) receive a mailed that includes pamphlets and resources on quitting, information about quit smoking support options (MyQuitBuddy App) and a selection of merchandise; (b) be offered a referral to Aboriginal Quitline; and (c) be offered a free 12-week mail out course of combination NRT. Outcome data will be obtained using quantitative surveys and qualitative Yarning. Effectiveness outcomes will include assessment of 7-day point prevalence, continuous abstinence and quit attempts at 3- and 6-month follow-up. Implementation outcomes will include assessment of recruitment and retention rates, intervention uptake and adherence, and intervention acceptability.Cessation data will be analysed using an intention-to-treat principle with all individuals lost to follow-up considered as smoking. Yarns will be analysed by Aboriginal and Torres Strait Islander members of the research team privileging Collaborative Yarning, with the support of a reflexive thematic analysis approach that will identify themes while also reflecting potential biases and perspectives of the researcher throughout the analysis process.
Ethics approvals were obtained from Aboriginal Health and Medical Research Council Ethics Committee of NSW (1894/21) and the University of Newcastle (H-2022-0174). Findings will be disseminated through publications, conference presentations and sharing with relevant government bodies.
Australian New Zealand Clinical Trials Registry (ACTRN12623001021662).
吸烟是可预防的首要死因，也是导致原住民和托雷斯海峡岛民健康状况不佳的最主要风险行为。迫切需要创新方法来支持降低吸烟率。本研究将评估一项邮寄戒烟支持计划的实施情况和效果，该计划为原住民和托雷斯海峡岛民提供尼古丁替代疗法（NRT）。
2023年至2025年在澳大利亚进行一项混合型1类有效性-实施试验。将通过社交媒体招募500名年龄在16岁以上的吸烟原住民和托雷斯海峡岛民作为样本。所有参与者将：（a）收到一份邮寄包裹，其中包括关于戒烟的宣传册和资源、戒烟支持选项（MyQuitBuddy应用程序）的信息以及一系列商品；（b）获得转介至原住民戒烟热线的机会；（c）获得一个为期12周的免费邮寄组合NRT疗程。将通过定量调查和定性交流获取结果数据。有效性结果将包括在3个月和6个月随访时评估7天点患病率、持续戒烟率和戒烟尝试情况。实施结果将包括评估招募率和保留率以及干预措施的采用和依从情况，还有干预措施的可接受性。戒烟数据将采用意向性分析原则进行分析，所有失访个体视为仍在吸烟。交流内容将由研究团队中的原住民和托雷斯海峡岛民成员在协作交流的前提下进行分析，并辅以反思性主题分析方法，该方法在识别主题的同时，还将在整个分析过程中反映研究人员的潜在偏见和观点。
已获得新南威尔士州原住民健康与医学研究理事会伦理委员会（1894/21）和纽卡斯尔大学（H-2022-0174）的伦理批准。研究结果将通过出版物、会议报告以及与相关政府机构分享的方式进行传播。
澳大利亚新西兰临床试验注册中心（ACTRN12623001021662）
